Neurocrine Biosciences NBIX
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 141.83 | 3,253 | 4.91 | 154 | 3.46 | 4,632 |
| 2025Q3 | 140.38 | 3,004 | 7.35 | 210 | 5.14 | 4,266 |
| 2025Q2 | 125.69 | 2,694 | 4.11 | 108 | 2.84 | 3,890 |
| 2025Q1 | 110.60 | 2,536 | 0.31 | 8 | 0.21 | 3,688 |
| 2024Q4 | 136.50 | 2,590 | 3.88 | 103 | 2.84 | 3,719 |
| 2024Q3 | 115.22 | 2,719 | 4.97 | 130 | 3.80 | 3,535 |
| 2024Q2 | 137.67 | 2,509 | 2.66 | 65 | 1.92 | 3,305 |
| 2024Q1 | 137.92 | 2,386 | 1.88 | 43 | 1.29 | 3,472 |
| 2023Q4 | 131.76 | 2,232 | 6.98 | 148 | 4.84 | 3,251 |
| 2023Q3 | 112.50 | 2,002 | 4.31 | 83 | 3.04 | 2,848 |
| 2023Q2 | 94.30 | 1,853 | 5.40 | 96 | 3.84 | 2,613 |
| 2023Q1 | 101.22 | 1,685 | -4.52 | -77 | -3.24 | 2,360 |
| 2022Q4 | 119.44 | 1,708 | 5.47 | 89 | 3.94 | 2,369 |
| 2022Q3 | 106.21 | 1,545 | 4.62 | 69 | 3.30 | 2,143 |
| 2022Q2 | 97.48 | 1,423 | -1.20 | -17 | -0.81 | 2,006 |
| 2022Q1 | 93.75 | 1,391 | 1.01 | 14 | 0.66 | 2,145 |
| 2021Q4 | 85.17 | 1,374 | -0.54 | -7 | -0.36 | 2,073 |
| 2021Q3 | 95.91 | 1,346 | 1.71 | 23 | 1.13 | 2,017 |
| 2021Q2 | 97.32 | 1,279 | 3.40 | 42 | 2.22 | 1,956 |
| 2021Q1 | 97.25 | 1,206 | 2.75 | 32 | 1.79 | 1,846 |